Advertisement
For athletes with cardiac arrest

Attempts to Prevent Tongue Swallowing Hinder Resuscitation

0
In 17 videos, initial intervention after athlete collapse was attempt to prevent tongue swallowing
In patients with type 2 diabetes being treated with a dipeptidyl peptidase-4 inhibitor

Anagliptin Effect on LDL in T2DM Via ApoB-100 Synthesis

0
Improvement appears mediated, at least in part, through suppression of apoB-100 synthesis
The American College of Physicians does not support the legalization of physician-assisted suicide

ACP Does Not Support Legalization of Assisted Suicide

0
Legalization would affect trust in the patient-physician relationship, and in the medical profession
The incidence of deaths or cardiac arrest is 1.74 per 100

Deaths, Cardiac Arrest Not Rare in Triathlon Participants

0
Incidence of death or cardiac arrest 1.74 per 100,000 participants; higher incidence in men, with age
A multicomponent intervention is associated with greater reduction in systolic and diastolic blood pressure than usual care over 18 months

Multicomponent Intervention Linked to Greater Drop in BP

0
Intervention beneficial over 18 months for low-income adults in Argentina with uncontrolled HTN
Having no partner is associated with a lower frequency of home blood pressure monitoring

AHA: Home BP Monitoring Down for Those Without Partners

0
Having, being aware of/treated for hypertension linked to increased frequency of home BP monitoring
Some adolescents

AHA: Target Organ Damage From HTN Also Seen in Teenagers

0
Sixteen percent of teenagers had left ventricular hypertrophy with SBP below the 95th percentile
A multifaceted quality improvement program improves blood pressure control over a six-month period

AHA: Multifaceted Intervention Improves BP Control

0
Increase in BP control from 65.6% to 74.8%, with significant increase in control in 12 of 16 practices
For patients after an ischemic stroke or transient ischemic attack

Greater Benefit for Pioglitazone in High-Risk Patients Post Stroke

0
Patients at higher risk for stroke or MI derive greater benefit from pioglitazone versus low-risk patients
Postmarketing adverse events related to the CardioMEMS HF System are infrequent

Postmarketing Adverse Events Low for CardioMEMS HF System

0
Of the 5,500 implants during the first three years after FDA approval, 155 reports described 177 events